View clinical trials related to Cerebral Vascular Accident (CVA).
Filter by:The purpose of this randomized controlled study is to 1. Examine the feasibility of a home Mirror therapy (MT) program in the NYC metropolitan area; 2. Evaluate the effectiveness of home MT versus traditional home exercise program; and 3. Evaluate the superiority of unimanual or bimanual MT intervention protocols for chronic stroke subjects with moderate hand deficits. Subjects from occupational therapy at the Ambulatory Care Center of NYU Langone Center with a diagnosis of cerebral vascular accident (CVA) or stroke will be divided into three (3) groups: - Control Group subjects will participate in standard occupational therapy rehabilitation protocol plus a traditional home based exercise program. - Experimental group 1 subjects will participate in standard rehabilitation protocol plus unimanual home based mirror therapy program - Experimental group 2 subjects will participate in standard rehabilitation protocol plus bimanual home based mirror therapy program.
In the USA, every year 795,000 patients suffer a cerebral vascular accident (CVA), which represents a yearly cost of $73.7 billion. CVA is the third main cause of death and the main source of acquired handicap in adults, as a result it is now a key priority in public health and part of " The CVA National Action Plan 2013-2014". Copeptin is a polypeptide, by- product of Vasopressin metabolism. The increase of Copeptin plasma level, as for Vasopressin, is connected to hydric balance disorders found in cardio-vascular, renal and endocrine diseases. This link has already shown its interest in the early diagnosis of myocardial infarction and, in a more indirect way, CVA. Copeptin is associated with acute endogenous stress. It seems to have interesting potential in the diagnosis of CVA by its negative predictive value like D-dimeres in pulmonary embolism. Proadrenomedullin and Brain Natriuretic Peptide (BNP) are both associated with the prognosis of cardio-vascular diseases and could be interesting in evaluating CVA prognosis.